Markowitz LE , Dunne EF, Saraiya M., Lawson HW, Chesson H., Unger ERQuadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) . MMWR Recomm Rep. 2007;56:1-24.
2.
Whitehead SJ , Cui KX, De AK, Ayers T., Effler PVIdentifying risk factors for underimmunization by using geocoding matched to census tracts: a statewide assessment of children in Hawaii. Pediatrics. 2007;120: e535-e542.
3.
Slonim AB, Roberto AJ, Downing CR, et al. Adolescents’ knowledge, beliefs, and behaviors regarding hepatitis B: insights and implications for programs targeting vaccine-preventable diseases. J Adolesc Health. 2005;36:178-186.
4.
Middleman ABRace/ethnicity and gender disparities in the utilization of school-based hepatitis B immunization initiative. J Adolesc Health. 2004;34:414-419.
5.
National Vaccine Advisory Committee.Strategies to sustain success in childhood immunizations: consensus statement . JAMA. 1999;282:363-370.
6.
Macdonald V. , Dore GJ, Amin J., van Beek I.Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health. 2007;4:27-30.
7.
Kollar LM, Rosenthal SL, Biro FMHepatitis B vaccine series compliance in adolescents. Pediatr Infect Dis J. 1994;13:1006-1008.
8.
Scarinci IC, Garces-Palacio IC, Partridge EEAn examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health ( Larchmt). 2007;16:1224-1233.
9.
Shui IM, Weintraub ES, Gust DAParents concerned about vaccine safety: differences in race/ethnicity and attitudes. Am J Prev Med. 2006;31:244-251.
10.
Koff RSHepatitis B.school-based vaccination programmes in the USA: a model for hepatitis A and B. Vaccine. 2000;18(suppl 1):S77-S79.
11.
Buck MLQuadrivalent human papillomavirus (HPV) recombinant vaccine. Pediatr Pharm. 2006;12(11).
